Cervidx
"Cervidx" is a trademark owned by Roche Diagnostics GmbH, filed at the WIPO on September 20, 2006. It is on file and covers classes 1, 5, 9, 10, 42 and 44.
- Status
- Mixed
- Filed
- September 20, 2006
- Registered
- Not yet
- Expires
- September 20, 2026
- Application no.
- Not recorded
- Registration no.
- 918309
- Office
- WIPO
- World Intellectual Property Organization
- Mark type
- Trademark
- 6 classes
Who owns Cervidx
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Roche Diagnostics GmbH
Representative
F. Hoffmann-La Roche AG
F. Hoffmann-La Roche AG
What the mark covers
The products and services Cervidx is filed for, grouped by Nice class.
Chemical preparations and reagents for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant cancerous conditions, malignant cancerous conditions, cancer and inborn deficiencies for scientific or research use.
Pharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn deficiencies; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous, conditions, cancer and inborn deficiencies in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents for detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn deficiencies; medical diagnostic preparations namely in-vitro and in-vivo diagnostic preparations, diagnostic immunocytochemical preparations, diagnostic immunohistochemical preparations, diagnostic histology preparations, diagnostic cytology preparations, diagnostic liquid-immuno-assay preparations, diagnostic solid-phase immuno-assay preparations, diagnostic testing strips, diagnostic dip-stick tests, diagnostic preparations for use at point of care, diagnostic lateral-flow assay preparations, diagnostic flow-through assay preparations, diagnostic immuno-chromatographic preparations; diagnostic equipment for medical purposes, namely strips, cotton sticks, swabs, cotton and tampons for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies as indicated above.
Laboratory equipment for diagnostic purposes, in particular test tubes, multiwell test plates, multiwell ELISA (enzyme linked immunosorbent assay) plates and chromatography columns for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating biological material and samples.
Diagnostic testing machines, namely point-of-care testing machines, diagnostic liquid-immuno-assay machines, diagnostic immunocytochemical machines, diagnostic immunohistochemical machines, diagnostic histology machines, diagnostic cytology machines, diagnostic solid-phase immuno-assay machines, diagnostic ELISA (enzyme linked immunosorbent assay) testing machines, diagnostic immuno-chromatographic machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies as indicated above; diagnostic equipment for medical purposes including syringes, needles, brushes, spatulas and sample receptacles for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies as indicated above; diagnostic nucleic acid detection machines, diagnostic nucleic acid amplification machines, diagnostic immuno-histology machines and diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies as indicated above; diagnostic apparatus and instruments, namely hand-held, table-top and floor-standing centrifugal, gravitational-separating, electrophoretic, chromatographic, conductometric, potentiometric, spectrometric, spectro-photometric, radiologic (electro)magnetic-resonance, histological, microscopic or in-vivo imaging machines and apparatus, automated and non-automated cellular imaging devices, automated and non-automated microscopy devices, automated and non-automated imaging analysis devices for use in preparing, enriching, concentrating, testing, analysing and evaluating of biological material and samples in connection with early diagnosis, diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies as indicated above for clinical and medical laboratory use.
Scientific analysis in the fields of chemistry, biology and molecular biology, laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceutical, chemical and diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services.
Medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn deficiencies in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds.
About Cervidx
Who owns the trademark "Cervidx"?
The WIPO trademark "Cervidx" is owned by Roche Diagnostics GmbH.
What is the status of "Cervidx"?
Its status at the WIPO is: mixed.
Get this data via the API
Everything on this page comes from the Signa API. Pull Cervidx and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_77a486a5-e57d-4d4a-a8b6-b8e7616d40a2
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_77a486a5-e57d-4d4a-a8b6-b8e7616d40a2",
"object": "trademark",
"mark_text": "Cervidx",
"status": {
"primary": "mixed",
"stage": "mixed"
},
"office_code": "WO",
"application_number": null,
"filing_date": "2006-09-20",
"nice_classes": [
1,
5,
9,
10,
42,
44
],
"owners": [
{
"name": "Roche Diagnostics GmbH",
"entity_id": "ent_019fbd1b-94d3-7054-b017-0c3d288ff711"
}
]
}